Basit öğe kaydını göster

dc.contributor.authorÇelik, Uğur
dc.contributor.authorAlagöz, Neşe
dc.contributor.authorYıldırım, Yusuf
dc.contributor.authorAğca, Alper
dc.contributor.authorMarshall, John
dc.contributor.authorMuller, David
dc.contributor.authorYılmaz, Ömer Faruk
dc.date.accessioned2020-11-20T16:20:13Z
dc.date.available2020-11-20T16:20:13Z
dc.date.issued2013
dc.identifier.issn0886-3350
dc.identifier.urihttps://doi.org/10.1016/j.jcrs.2012.08.066
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3869
dc.descriptionWOS: 000314625100013en_US
dc.descriptionPubMed ID: 23332252en_US
dc.description.abstractPURPOSE: To assess the safety, predictability, and stability of a new microwave thermokeratoplasty procedure to correct myopia. SETTING: Cornea and refractive surgery subspecialty. DESIGN: Prospective clinical trial. METHOD: Thermokeratoplasty was performed in myopic eyes at a single center in Turkey from June 2009 to June 2010. The attempted corrections ranged from -1.25 to -5.75 diopters (D). The main outcome measures were changes in logMAR uncorrected distance visual acuity (UDVA) and in keratometry (K) values. RESULTS: The procedure was performed in 33 eyes (patients aged 20 to 45 years). The mean preoperative logMAR UDVA (0.76 +/- 0.24 [SD]) significantly improved to 0.19 +/- 0.20 at 1 month, postoperatively. By 3 months, the mean UDVA had markedly regressed to 0.59 +/- 0.29; however, the residual improvement remained statistically significant. At 12 months, the mean logMAR UDVA was 0.72 +/- 0.26. The mean K values were 43.9 +/- 1.36 D preoperatively, 41.25 +/- 2.63 D at 1 month, 43.4 +/- 1.69 D at 3 months, and 44.1 +/- 1.09 D at 12 months. The mean endothelial cell density was 2836 +/- 342 cells/mm(2) preoperatively and were statistically unchanged 12 months postoperatively (2732 +/- 353 cell/mm(2)). No patient lost lines of corrected distance visual acuity by 12 months postoperatively. CONCLUSIONS: The new thermokeratoplasty procedure produced the desired reduction in myopia and improvement in postoperative UDVA 1 month postoperatively without significant side effects. However, early and complete regression shows the need for further development of this technique.en_US
dc.description.sponsorshipAvedro, Inc., Boston, Massachusetts, USAen_US
dc.description.sponsorshipSupported by grants from Avedro, Inc., Boston, Massachusetts, USA.en_US
dc.item-language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMyopiaen_US
dc.titleNew method of microwave thermokeratoplasty to correct myopia in 33 eyes: One-year resultsen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Eğitim ve Araştırma Hastanesien_US
dc.contributor.institutionauthorAlagöz, Neşe
dc.identifier.doi10.1016/j.jcrs.2012.08.066
dc.identifier.volume39en_US
dc.identifier.issue2en_US
dc.identifier.startpage225en_US
dc.identifier.endpage233en_US
dc.relation.journalJournal of Cataract and Refractive Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster